The ESMO Tumour Portals allow you to find the key educational resources in your field of interest
ESMO members: Browse through the ESMO Glossary of Molecular Biology in Cancer online
ESMO E-Learning platform now has a new look and improved features. V-Learning modules include educational videos. Available on all browsers and mobile devices!
29 Jul 2014
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended granting marketing authorisations for ibrutinib and...
28 Jul 2014
The latest National Institute of Health and Care Excellence recommendations hail new drug options for prostate cancer and skin cancer
25 Jul 2014
Preoperative radiotherapy before total mesorectal excision for rectal cancer has little effect on overall quality of life 14 years later, despite...
24 Jul 2014
Negative phase III trial results bring into question the use of neoadjuvant chemotherapy for the management of locally advanced head and neck cancer
R.Coleman explains how the trial results can help plan treatment for women with metastatic breast cancer, highlighting advantages of a less intensified approach. The study was requested by regulatory bodies, originally with placebo in the comparator arm. Due to failed recruitment, the study design was changed. Further trials on bisphosphonates duration are no longer needed.